Click here to

Session: Therapy: External Beam: treatment planning Optimization [Return to Session]

NYU Clinical Experience with Total Body Irradiation: From 3D Laterals to Image-Guided VMAT

P Galavis*, C Hitchen, A Mccarthy, M Malin, S Taneja, S Ayyalasomayajula, Y Yuan, N Gerber, D Barbee, J Teruel, NYU Langone Medical Center, New York, NY

Presentations

MO-IePD-TRACK 5-6 (Monday, 7/26/2021) 5:30 PM - 6:00 PM [Eastern Time (GMT-4)]

Purpose: Patients receiving myeloablative total body irradiation (TBI) doses ≥ 12Gy are at risk of developing interstitial pneumonitis. At our institution, TBI transitioned from extended distance opposed Laterals to image-guided VMAT, in an effort to improve coverage while sparing lungs and kidneys. This work presents a dosimetric comparison between 3D Laterals and VMAT.

Methods: Nine patients were treated with VMAT as part of an ongoing phase II single-arm clinical trial. VMAT patients were CT-simulated supine, with thermoplastic masks for head/neck, chest/abdomen/pelvis and feet. VMAT planning (12Gy (n=6) or 13.2Gy (n=3) in 8-BID fractions) utilizes 6MV multi-isocentric arcs and AP/PA beams to treat the upper and lower body, respectively. Ten 3D Lateral patients were CT-simulated supine with arms positioned/immobilized for lung shielding, with rice compensation between legs/feet. Laterals plan (12Gy in 8-BID fractions) uses 15MV, beam spoiler, head compensation, and subfields to maintain coverage and mean-lungs dose <10.5Gy. Target (Body-5mm, extending 3mm into lungs and kidneys for VMAT; Body-2cm for Laterals) coverage was evaluated at V100%, and D98% (percentage of Rx). Absolute dose to lungs and kidneys were reported

Results: Median Target V100% and D98% for VMAT was 93.2% (Range: 95.6% to 92.1%) and 90.2% (94.3% to 88.3%), whereas for Laterals V100% and D98% was 57.3% (66.5% to 46.3%) and 80.6% (75.5% to 84%). The median Lung mean dose was 7.6Gy (7.3Gy to 7.9Gy) for VMAT. The median mean dose to kidney was 10.4Gy (10.1Gy to 10.7Gy) for VMAT, and 12.5Gy (11.9Gy to 13.5Gy) for Laterals.

Conclusion: We have established a VMAT-TBI program for patients requiring myeloablative irradiation. Improvement in target coverage is demonstrated by V100% and D98%, while reducing the mean dose to the lungs significantly from 10.5Gy to 8Gy.

ePosters

    Keywords

    Treatment Planning, TBI, Dosimetry

    Taxonomy

    TH- External Beam- Photons: Development (new technology and techniques)

    Contact Email

    Share: